The February 2009 newsletter presents concise summaries of important developments in U.S. patent law occurring during the month of January, 2009. Developments include:

1. Federal Circuit raises questions as to patent eligibility under § 101 of systems carrying out patent ineligible processes

2. Providing information to patient on how a drug product worked did not claim patentable subject matter

3. Four obviousness rulings from the Federal Circuit

4. Statements made at oral hearing before BPAI held to create a disavowal of claim scope

5. Use of “i.e.” in specification, rather than “e.g.” limited claim scope

6. Alleged false marking of over 15,000 products was only a single offense

7. Patents held unenforceable against accused infringer based on pre-suit destruction of documents